| 1. Xiaowei Sha#, Jiaqian Li, Yunlong Fang, Jingjie Feng, Yasong Feng, Jing Wang, Yang Si, Feng Li, Shan Cheng*, Wei Ding.Enhanced tumor suppression in patientderived temozolomide-resistant glioblastoma cells using a combination treatment of Olaparib and FK866.BMC Cancer.2025.25(1).1174.SCI（含SCIE） |
| 2. Zhicheng Ge, Jing Wang, Libing He, Meng Zhao, Yang Si, Siyuan Chang, Guoyan Zhang, Shan Cheng*, Wei Ding.Reconstruction of cancer marker analysis with holistic anatomical precision implicates heterogeneity development during breast tumor progression..Discover Oncology.2024.15(1).564.SCI（含SCIE） |
| 3. H Niu, M Zhao, J Huang, J Wang, Y Si, S Cheng, W Ding.UHMK1-dependent phosphorylation of Cajal body protein coilin alters 5-FU sensitivity in colon cancer cells.Cell Commun Signal.2022.20(1).18.SCI（含SCIE） |
| 4. Mengtian Cui , Qingfang Zhao, Jing Wang, Yang Si, Shan Cheng*, Wei Ding*.ATF6-mediated unfolded protein response facilitates AAV2 transduction by releasing the suppression of AAV receptor on ER stress.Journal of Virology.2022.96(3).e0110321.SCI（含SCIE） |
| 5. Jing Niu, Rui-Qi Gao, Meng-Tian Cui, Chen-Guang Zhang, Shen-Tao Li, Shan Cheng*, Wei Ding*.Suppression of TCAB1 expression induced cellular senescence by lessening proteasomal degradation of p21 in cancer cells.Cancer Cell International.2021.21(1).26.SCI（含SCIE） |
| 6. Jing Huang, Mu Hu, Huan Niu, Jing Wang, Yang Si, Shan Cheng*, Wei Ding*.Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels.BMC Cancer.2021.21(1).750.SCI（含SCIE） |
| 7. Chang Siyuan, Huang Jing, Niu Huan, Wang Jing, Si Yang, Bai Zhigang, Cheng Shan*, Ding Wei. .Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5‑FU treatment..Cancer Cell International.2020.20.452.SCI（含SCIE） |
| 8. Yang Fenglian(#); Hu Mu(#); Chang Siyuan; Huang Jing; Si Yang; Wang Jinghui; Cheng Shan*; Jiang Wenguo.Alteration in the sensitivity to crizotinib by Na+/H+ exchanger regulatory factor 1 is dependent to its subcellular localization in ALK-positive lung cancers.BMC Cancer.2020.20(1).202.SCI（含SCIE） |
